Clin2
NCT06158126Likely a fitRecruiting

Pregnancy and infant health outcomes study

Pre-exposure ProphylaxisHIV PreventionPregnancy Related

Part of Infections, Women’s health & pregnancy clinical trials.

This study follows pregnant women and their babies to see how well HIV prevention medicines work during pregnancy. It aims to help keep both mother and baby healthy.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
621 people
Ages
15 years to 55 years
Study type
Interventional

Who can take part

  • You are pregnant (confirmed by a test or ultrasound).
  • You are 15 years or older.
  • You are eligible for PrEP (HIV prevention medicine) under Malawi's guidelines.
  • You have tested negative for HIV and hepatitis B.
  • You weigh more than 35 kg (about 77 lbs).
  • You are willing to stay in the Bwaila area for the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06506188Recruiting
Improving HIV prevention for breastfeeding women in Malawi

This study looks at how to make it easier for women in Malawi to stay on PrEP after giving birth while breastfeeding. Researchers will check medical records and ask some women to do a short survey and a finger stick blood test.

Lilongwe
NCT06493357Recruiting
Improving HIV testing and care for mothers and babies in Malawi

This study is testing a new way to find and treat HIV in pregnant women and new mothers in Malawi. It may help prevent passing HIV from mother to baby.

Lilongwe, Central Region
NCT06226155Recruiting
HIV prevention support for pregnant women in Zimbabwe

This study in Zimbabwe tests a program to help pregnant women start and stay on PrEP (medication that prevents HIV). It aims to make PrEP easier to use during pregnancy for women who are at risk of HIV.

Harare
NCT05624931Recruiting
Helping pregnant women stay on PrEP after starting it

This study tries to reduce the psychological barriers that make it hard for pregnant or postpartum women to keep taking PrEP. It may help by offering support tailored to stress, trauma symptoms, or depression—especially soon after PrEP is started.

Boston, Massachusetts
NCT04405700Recruiting
Tracking birth outcomes and birth defects after delivery

This study follows pregnant people and their babies to better measure adverse outcomes and possible congenital (from birth) conditions. It may help improve how birth risks and birth defects are identified and recorded at the clinic.

Eldoret
NCT07579754Recruiting
Understanding Women's HIV Prevention Medicine Choices in Malawi

This study aims to understand why some women in Malawi stopped taking PrEP (a medicine that prevents HIV) and what could help them stay on treatment. Researchers will contact women who started PrEP but missed their appointments to learn about their experiences and barriers.

Blantyre

Hear when a new Pre-exposure Prophylaxis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.